Piperazine sulfonamides as DPP-IV inhibitors: Synthesis, induced-fit docking and in vitro biological evaluation

Data publikacji: 03 kwi 2021

Zakres stron: 631 - 643

Przyjęty: 20 paź 2020

DOI: https://doi.org/10.2478/acph-2021-0034

Słowa kluczowe

piperazine sulfonamide, dipeptidyl peptidase-IV inhibitor, diabetes mellitus, induced-fit docking

© 2021 Reema Abu Khalaf et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.